Article Versions Notes

Marinelli L, Beccuti G, Zavattaro M, Cagnina S, Gesmundo I, Bona C, Lopez C, Scabini S, Canta F, Mornese Pinna S, et al. Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 Pneumonia. Biomedicines. 2022; 10(4):820. https://doi.org/10.3390/biomedicines10040820

Marinelli, Lorenzo, Guglielmo Beccuti, Marco Zavattaro, Serena Cagnina, Iacopo Gesmundo, Chiara Bona, Chiara Lopez, Silvia Scabini, Francesca Canta, Simone Mornese Pinna, and et al. 2022. "Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 Pneumonia" Biomedicines 10, no. 4: 820. https://doi.org/10.3390/biomedicines10040820

Marinelli, L., Beccuti, G., Zavattaro, M., Cagnina, S., Gesmundo, I., Bona, C., Lopez, C., Scabini, S., Canta, F., Mornese Pinna, S., Lupia, T., Di Bisceglie, C., Ponzetto, F., Settanni, F., De Rosa, F. G., Ghigo, E., & Motta, G. (2022). Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 Pneumonia. Biomedicines, 10(4), 820. https://doi.org/10.3390/biomedicines10040820